Latest Breaking News On - Ken gruber - Page 3 : comparemela.com

Endevica Bio is developing a new treatment for cachexia, a severe wasting disease critical to patients’ survival in cancer and other conditions.

United statesEndevica bioKen gruberWayne kobersteinRussell potterfieldendevica bioRussell potterfieldNational cancer institute institutes of healthOregon health sciences universitySmall business innovation research phaseUniversity of missouri college veterinary medicineExecutive editorLife science leaderPotterfieldendevica bioDaniel marksOregon health sciencesTotal raised